Select Publications
Journal articles
2019, 'Pneumatic Compression in Venous Thromboprophylaxis.', N Engl J Med, 381, pp. 94, http://dx.doi.org/10.1056/NEJMc1905933
,2019, 'Pneumatic Compression in Venous Thromboprophylaxis.', N Engl J Med, 381, pp. 94 - 95, http://dx.doi.org/10.1056/NEJMc1905933
,2019, 'Pneumatic Compression in Venous Thromboprophylaxis. Reply', The New England journal of medicine, 381, pp. 95, http://dx.doi.org/10.1056/NEJMc1905933
,2019, 'A Systematic Review of Outcome Measures Employed in Aneurysmal Subarachnoid Hemorrhage (aSAH) Clinical Research', Neurocritical Care, 30, pp. 534 - 541, http://dx.doi.org/10.1007/s12028-018-0566-0
,2019, 'Adjunctive intermittent pneumatic compression for venous thromboprophylaxis', New England Journal of Medicine, 380, pp. 1305 - 1315, http://dx.doi.org/10.1056/NEJMoa1816150
,2019, 'Life after sepsis: An international survey of survivors to understand the post-sepsis syndrome', International Journal for Quality in Health Care, 31, pp. 191 - 198, http://dx.doi.org/10.1093/intqhc/mzy137
,2019, 'A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III', Critical Care and Resuscitation, 21, pp. 63 - 68
,2019, 'Sepsis and septic shock: current approaches to management', Internal Medicine Journal, 49, pp. 160 - 170, http://dx.doi.org/10.1111/imj.14199
,2019, 'Sex and mortality in septic severe acute kidney injury', Journal of Critical Care, 49, pp. 70 - 76, http://dx.doi.org/10.1016/j.jcrc.2018.10.017
,2018, 'Do trials that report a neutral or negative treatment effect improve the care of critically ill patients? Yes', Intensive Care Medicine, 44, pp. 1985 - 1988, http://dx.doi.org/10.1007/s00134-018-5129-5
,2018, 'Erratum to: Intravenous fluid therapy in critically ill adults (Nature Reviews Nephrology, (2018), 14, 9, (541-557), 10.1038/s41581-018-0044-0)', Nature Reviews Nephrology, 14, pp. 717, http://dx.doi.org/10.1038/s41581-018-0060-0
,2018, 'Six subphenotypes in septic shock: Latent class analysis of the PROWESS Shock study', Journal of Critical Care, 47, pp. 70 - 79, http://dx.doi.org/10.1016/j.jcrc.2018.06.012
,2018, 'Sepsis incidence and mortality are underestimated in Australian intensive care unit administrative data', Medical Journal of Australia, 209, pp. 255 - 260, http://dx.doi.org/10.5694/mja18.00168
,2018, 'Women in Intensive Care study: A preliminary assessment of international data on female representation in the ICU physician workforce, leadership and academic positions', Critical Care, 22, http://dx.doi.org/10.1186/s13054-018-2139-1
,2018, 'Intravenous fluid therapy in critically ill adults', Nature Reviews Nephrology, 14, pp. 541 - 557, http://dx.doi.org/10.1038/s41581-018-0044-0
,2018, 'Glucocorticoids with or without Fludrocortisone in Septic Shock Reply', NEW ENGLAND JOURNAL OF MEDICINE, 379, pp. 895 - 895, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443047800023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Glucocorticoids with or without Fludrocortisone in Septic Shock.', N Engl J Med, 379, pp. 894, http://dx.doi.org/10.1056/NEJMc1804993
,2018, 'Glucocorticoids with or without Fludrocortisone in Septic Shock.', N Engl J Med, 379, pp. 894, http://dx.doi.org/10.1056/NEJMc1804993
,2018, 'Glucocorticoids with or without Fludrocortisone in Septic Shock.', N Engl J Med, 379, pp. 895 - 896, http://dx.doi.org/10.1056/NEJMc1804993
,2018, 'Glucocorticoids with or without Fludrocortisone in Septic Shock.', N Engl J Med, 379, pp. 894 - 895, http://dx.doi.org/10.1056/NEJMc1804993
,2018, 'Glucocorticoids with or without Fludrocortisone in Septic Shock.', N Engl J Med, 379, pp. 893, http://dx.doi.org/10.1056/NEJMc1804993
,2018, 'Glucocorticoids with or without Fludrocortisone in Septic Shock.', N Engl J Med, 379, pp. 893 - 894, http://dx.doi.org/10.1056/NEJMc1804993
,2018, 'Health-related outcomes of critically ill patients with and without sepsis', Intensive Care Medicine, 44, pp. 1249 - 1257, http://dx.doi.org/10.1007/s00134-018-5274-x
,2018, 'Should hydroxyethyl starch be banned? – Authors' reply', The Lancet, 392, pp. 119, http://dx.doi.org/10.1016/S0140-6736(18)31179-6
,2018, 'Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis', Intensive Care Medicine, 44, pp. 1003 - 1016, http://dx.doi.org/10.1007/s00134-018-5197-6
,2018, 'Renal replacement therapy intensity for acute kidney injury and recovery to dialysis independence: A systematic review and individual patient data meta-analysis', Nephrology Dialysis Transplantation, 33, pp. 1017 - 1024, http://dx.doi.org/10.1093/ndt/gfx308
,2018, 'Long-Term outcomes of the ADRENAL trial', New England Journal of Medicine, 378, pp. 1744 - 1745, http://dx.doi.org/10.1056/NEJMc1803563
,2018, 'Day or overnight transfusion in critically ill patients: does it matter?', Vox Sanguinis, 113, pp. 275 - 282, http://dx.doi.org/10.1111/vox.12635
,2018, 'Higher versus Lower Continuous Renal Replacement Therapy Intensity in Critically ill Patients with Liver Dysfunction', Blood Purification, 45, pp. 36 - 43, http://dx.doi.org/10.1159/000480224
,2018, 'The dark ages of maternal sepsis: time to be enlightened', British Journal of Anaesthesia, 120, pp. 626 - 628, http://dx.doi.org/10.1016/j.bja.2017.12.032
,2018, 'Statistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: A study protocol for a randomized controlled trial', Trials, 19, pp. 182, http://dx.doi.org/10.1186/s13063-018-2534-6
,2018, 'Adjunctive glucocorticoid therapy in patients with septic shock', New England Journal of Medicine, 378, pp. 797 - 808, http://dx.doi.org/10.1056/NEJMoa1705835
,2018, 'Protocol summary and statistical analysis plan for the intensive care unit randomised trial comparing two approaches to oxygen therapy (ICU-ROX)', Critical Care and Resuscitation, 20, pp. 22 - 32
,2018, 'Hydroxyethyl starch solutions and patient harm', The Lancet, 391, pp. 736, http://dx.doi.org/10.1016/S0140-6736(18)30255-1
,2018, 'Correction to: Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials (Intensive Care Medicine, (2018), 44, 1, (1-11), 10.1007/s00134-017-5005-8)', Intensive Care Medicine, 44, pp. 277 - 278, http://dx.doi.org/10.1007/s00134-017-5023-6
,2018, 'Review article: Sepsis in the emergency department – Part 2: Investigations and monitoring', EMA - Emergency Medicine Australasia, 30, pp. 4 - 12, http://dx.doi.org/10.1111/1742-6723.12924
,2018, 'Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials', Intensive Care Medicine, 44, http://dx.doi.org/10.1007/s00134-017-5005-8
,2017, 'Intensive care unit randomised trial comparing two approaches to oxygen therapy (ICU-ROX): results of the pilot phase', Critical Care and Resuscitation, 19, pp. 344 - 354, http://dx.doi.org/10.1016/S1441-2772(23)00959-6
,2017, 'Lactate ≥2 mmol/L plus qSOFA improves utility over qSOFA alone in emergency department patients presenting with suspected sepsis', EMA - Emergency Medicine Australasia, 29, pp. 626 - 634, http://dx.doi.org/10.1111/1742-6723.12894
,2017, 'Review article: Sepsis in the emergency department – Part 1: Definitions and outcomes', EMA - Emergency Medicine Australasia, 29, pp. 619 - 625, http://dx.doi.org/10.1111/1742-6723.12886
,2017, 'Sepsis in Children: Global Implications of the World Health Assembly Resolution on Sepsis', Pediatric Critical Care Medicine, 18, pp. e625 - e627, http://dx.doi.org/10.1097/PCC.0000000000001340
,2017, 'Counting sepsis, an imprecise but improving science', JAMA - Journal of the American Medical Association, 318, pp. 1228 - 1229, http://dx.doi.org/10.1001/jama.2017.13697
,2017, 'The plasma-lyte 148 v saline (PLUS) study protocol: A multicentre, randomised controlled trial of the effect of intensive care fluid therapy on mortality', Critical Care and Resuscitation, 19, pp. 239 - 246
,2017, 'Gender parity in critical care medicine', American Journal of Respiratory and Critical Care Medicine, 196, pp. 425 - 429, http://dx.doi.org/10.1164/rccm.201701-0076CP
,2017, 'Recognizing sepsis as a global health priority — A WHO Resolution', New England Journal of Medicine, 377, pp. 414 - 417, http://dx.doi.org/10.1056/NEJMp1707170
,2017, 'Sepsis 3 from the perspective of clinicians and quality improvement initiatives', Journal of Critical Care, 40, pp. 315 - 317, http://dx.doi.org/10.1016/j.jcrc.2017.04.037
,2017, 'Reanalysis of the crystalloid versus hydroxyethyl starch trial (CHEST)', New England Journal of Medicine, 377, pp. 298 - 300, http://dx.doi.org/10.1056/NEJMc1703337
,2017, 'Comparison of fatal or irreversible events with extended-duration betrixaban versus standard dose enoxaparin in acutely Ill medical patients: An APEX trial substudy', Journal of the American Heart Association, 6, pp. e006015, http://dx.doi.org/10.1161/JAHA.117.006015
,2017, 'Withholding Pantoprazole for Stress Ulcer Prophylaxis in Critically Ill Patients: A Pilot Randomized Clinical Trial and Meta-Analysis∗', Critical Care Medicine, 45, pp. 1121 - 1129, http://dx.doi.org/10.1097/CCM.0000000000002461
,2017, 'Patterns of intravenous fluid resuscitation use in adult intensive care patients between 2007 and 2014: An international cross-sectional study', PLoS ONE, 12, pp. e0176292, http://dx.doi.org/10.1371/journal.pone.0176292
,